What It's like to live with Low-Risk MDS: patients share their stories
NCT ID NCT07008820
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study in Japan looked at how low-risk myelodysplastic syndrome (MDS) or unexplained anemia affects patients' daily lives. Researchers used questionnaires and interviews with 56 participants to understand symptoms, quality of life, and unmet needs. The goal was to capture the patient's voice to help improve future care and communication with doctors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROME (MDS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Local Institution - 0001
Minato-ku, Tokyo, 1050001, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New pill targets genetic weakness in Hard-to-Treat blood cancers
- New transplant cocktail aims to tame blood cancer without severe side effects
- Experimental drug tested for Post-Transplant blood cancers — but study halted early
- New drug cocktail shows promise for rare blood cancer
- New combo aims to cut infections in bone marrow cancer
- One donor, two transplants: could this end lifelong Anti-Rejection drugs?